| Literature DB >> 29507374 |
Songchao Li1,2,3, Jun Wang1,2,3, Erwei Zhang1,2,3, Wansheng Gao1, Jinjian Yang1,2,3, Zhankui Jia4,5,6.
Abstract
To evaluate the therapeutic effect of single-plane retroperitoneoscopic adrenalectomy. From February 2014 to March 2017, 251 patients underwent single-plane retroperitoneoscopic adrenalectomy, and their operative outcomes were compared with those of 98 patients who underwent anatomical three-plane retroperitoneoscopic adrenalectomy. Among 35 patients with a body mass index (BMI) of ≥30 kg/m2, their operative outcomes were compared between two operative procedures. The demographic data and perioperative outcomes of the patients were statistically analysed. The single-plane and three-plane groups were comparable in terms of estimated blood loss, time to oral intake, hospital stay, and incidence of complications among patients with similar baseline demographics. The single-plane group had a significantly shorter operation time (46.9 ± 5.8 vs 54.8 ± 7.0 mins, P < 0.0001) and lower analgesia requirement (56/251 vs 33/98, p = 0.03). For obese patients with a BMI of ≥30 kg/m2, single-plane adrenalectomy was also associated with a significantly shorter operation time(48.1 ± 6.2 vs 64.1 ± 5.1 mins, p < 0.0001). Single-plane retroperitoneoscopic adrenalectomy is feasible, safe, and effective in the treatment of adrenal masses <5 cm in size and provides a shorter operation time and better pain control than anatomical retroperitoneal adrenalectomy, especially in obese patients.Entities:
Mesh:
Year: 2018 PMID: 29507374 PMCID: PMC5838216 DOI: 10.1038/s41598-018-22433-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Patient demographics.
| Single plane group | Three planes group | P | |
|---|---|---|---|
| No. of patients | 251 | 98 | |
| Age (years) | 47.7 ± 5.9 | 46.2 ± 4.5 | 0.38 |
| Sex (M/F), n | 119/132 | 45/53 | 0.8 |
| BMI (kg/m2) | 26.6 ± 4.6 | 27.3 ± 4.7 | 0.58 |
| Tumor size, cm | 2.1 ± 0.51 | 2.4 ± 0.54 | 0.2 |
| Tumor side (right/left), n | 131/120 | 48/50 | 0.59 |
| Clinical diagnosis | |||
| Primary aldosteronism | 106 | 40 | 0.81 |
| Cushing’s syndrome | 37 | 18 | 0.4 |
| Pheochromocytoma | 55 | 25 | 0.47 |
| Nonfunctional tumor | 53 | 15 | 0.22 |
Data are presented as n or mean ± standard deviation. M, male; F, female; BMI, body mass index.
All patients, perioperative outcomes.
| Single plane group | Three planes group | P | |
|---|---|---|---|
| No. of patients | 251 | 98 | |
| Operative time(mins) | 46.9 ± 5.8 | 54.8 ± 7.0 | P < 0.0001 |
| EBL(mL) | 24.5 ± 9.2 | 25.1 ± 7.0 | P = 0.63 |
| No. of complications | 15 | 5 | P = 0.75 |
| Peritoneum tear | 5 | 2 | |
| Subcutaneous emphysema | 8 | 2 | |
| Postoperative fever | 2 | 1 | |
| Wound infection | 0 | 0 | |
| Analgesia requirement(N) | 56 | 33 | P = 0.03 |
| VAPS at 24 h | 4.5 ± 1.7 | 5.8 ± 1.7 | P = 0.02 |
| VAPS at discharge | 1.5 ± 0.8 | 1.7 ± 0.8 | P = 0.52 |
| Oral Intake(hours) | 23.6 ± 3.0 | 24.4 ± 3.3 | P = 0.46 |
| Hospital stay(d) | 6.8 ± 0.9 | 7.2 ± 0.9 | P = 0.34 |
Data are presented as n or mean ± standard deviation.
EBL, estimated blood loss; VAPS, visual analogue pain scale.
Demographics of patients with a body mass index of ≥30 kg/m2.
| Single plane group | Three planes group | P | |
|---|---|---|---|
| No. of patients | 22 | 13 | |
| Age (years) | 46.1 ± 3.8 | 41.2 ± 3.9 | 0.22 |
| Sex (M/F), n | 10/12 | 5/8 | 0.69 |
| BMI (kg/m2) | 32.4 ± 2.3 | 33.0 ± 2.2 | 0.55 |
| Tumor size, cm | 2.4 ± 0.4 | 2.2 ± 0.54 | 0.45 |
| Tumor side (right/left), n | 9/13 | 6/7 | 0.76 |
| Clinical diagnosis | |||
| Primary aldosteronism | 10 | 6 | 0.97 |
| Cushing’s syndrome | 3 | 1 | 0.59 |
| Pheochromocytoma | 4 | 4 | 0.39 |
| Nonfunctional tumor | 5 | 2 | 0.6 |
Data are presented as n or mean ± standard deviation.M, male; F, female; BMI, body mass index.
Perioperative outcomes of patients with a body mass index of ≥30 kg/m2.
| Single plane group | Three planes group | P | |
|---|---|---|---|
| No. of patients | 22 | 13 | |
| Operative time | 48.1 ± 6.2 | 64.1 ± 5.1 | P < 0.0001 |
| EBL(mL) | 23.3 ± 7.1 | 27.3 ± 3.3 | P = 0.06 |
| No. of complications | 2 | 1 | P = 0.89 |
| Peritoneum tear | 1 | 0 | |
| Subcutaneous | 1 | 0 | |
| Postoperative fever | 0 | 1 | |
| Wound infection | 0 | 0 | |
| Analgesia requirement(N) | 9 4 | P = 0.55 | |
| VAPS at 24 h | 5.6 ± 1.8 | 5.4 ± 1.8 | P = 0.7 |
| VAPS at discharge | 1.6 ± 0.7 | 1.8 ± 0.7 | P = 0.43 |
| Oral Intake(hours) | 25 ± 3.9 | 24 ± 3.6 | P = 0.5 |
| Hospital stay(d) | 6.9 ± 0.8 | 7.1 ± 0.5 | P = 0.44 |
Data are presented as n or mean ± standard deviation. EBL, estimated blood loss; VAPS, visual analogue pain scale.
Figure 1Port sites for single-plane retroperitoneal adrenalectomy. 1, 12-mm port below the 12th rib in the posterior axillary line. 2, 12-mm port (right side) or 5-mm port (left side) under the subcostal margin in the anterior axillary line. 3, 10-mm port above the iliac crest in the midaxillary line for the laparoscope. 4, 5-mm port placed ventral to and along a transverse line with the trocar above the iliac crest.
Figure 2Key procedures of single-plane retroperitoneal adrenalectomy (right side) and major intraoperative anatomical structures. (a) The anterior aspect of the adrenal tumour (AT) with perirenal fat was completely separated from anterior renal fascia(ARF). (b) The lateral side and bottom of the adrenal gland was exposed after dissection between the adrenal gland (AD) bottom and parenchymal surface of the upper kidney(KI) pole. psoas muscle(PM). (c) Anatomical three-plane adrenalectomy involves dissection of ventral side, lateral side and upper pole of kidney(UPK). (d) Single-plane adrenalectomy only involves dissection of ventral side of the kidney.